Monday, September 14, 2026

ONF Drops Heart-Pounding Teaser as Part of Their Highly Anticipated Return

ONF teases their upcoming album "ONF: MY IDENTITY" with a captivating music video for "The Stranger," showcasing dynamic choreography.

Rigetti’s Quantum Computing Dreams Hit Hard as Stock Dips 11%

Rigetti's stock plummeted nearly 11%, reflecting declining optimism in quantum computing despite a past surge of 1,071% over six months.

“Preparing for the Next Pandemic After COVID-19”…South Korea Accelerates Development of Homegrown mRNA Vaccines

The South Korean government is accelerating domestic mRNA vaccine development to secure an independent vaccine technology platform capable of responding rapidly to future pandemics.

Tag: drug

North KoreaKoreaKimMilitaryAISouth Koreamarketrelationsdevelopment

Mexico Recognizes South Korea’s MFDS: What This Means for Drug Approvals

Mexico recognizes South Korea's MFDS as a reference authority, streamlining drug approvals and enhancing market access for Korean firms.

Hyundai Bioscience’s Xafty Clears Genotoxicity Study, Supporting U.S. Phase 2 Respiratory Virus Trial Plans

Hyundai Bioscience's Xafty shows no genotoxicity in tests, aiding its Phase 2 trial plans for respiratory viral infections.

Moxidectin vs. Traditional Heartworm Preventatives: Which Offers Better Protection in 2026?

Reports of drug resistance in heartworm prevention highlight the need for moxidectin-based strategies to combat ML-resistant strains.

Revolutionary Drug Delivery: How Nasal Nanoparticles Target Glioblastoma with Magnetic Precision

Korean researchers developed a nasal drug delivery method using magnetic fields to target glioblastomas, significantly improving survival rates.

IVL3021 vs Wegovy: The Future of Long-Acting Obesity Treatments Revealed

Inventage Lab's IVL3021 shows promising long-term obesity treatment results, outperforming competitors with effective weight maintenance strategies.

Daewoong Pharmaceutical Gains Mexico Approval for Type 2 Diabetes Drug as Latin America Expansion Accelerates

Daewoong Pharmaceutical's type 2 diabetes drug Enblo has received approval in Mexico, a key market in Latin America.

Inventage Lab Showcases Next-Generation Monthly Obesity Injection Data Ahead of Global Experts at ADA

Inventage Lab presents its next-gen obesity treatment, reducing dosage frequency from weekly to monthly, to U.S. experts.

Inventage Lab Secures Patent for Semaglutide Formulation Aimed at Improving Oral Bioavailability

Inventage Lab secures a patent for a liposome formulation enhancing semaglutide's bioavailability, aiming to lead in obesity treatment.

A 90-Minute Cancer Infusion Could Soon Be Cut to 5 Minutes—and Celltrion Wants to Lead It

Celltrion has applied for EMA approval of Herzuma SC, a new breast cancer treatment, enhancing drug delivery and patient convenience.

Daewoong Pharmaceutical Completes Global Phase 2 Trials for First-in-Class IPF Treatment

Daewoong Pharmaceutical completes patient recruitment for a Phase 2 trial of Bersiporocin, a potential treatment for idiopathic pulmonary fibrosis.

KVMA and KIDS to Enhance the Safety Management of Narcotic Drugs in Veterinary Medicine

The KVMA and KIDS signed an MOU to enhance narcotic drug safety in veterinary medicine, promoting education and data utilization.

ADHD Medication Misconceptions: Why Korean Teens Are Misusing Study Drugs

ADHD medications are misused by teens as smart drugs. The Ministry of Food and Drug Safety expands education and AI monitoring to combat this.

Penetrium Bioscience Announces Finalization of New Clinical Strategy for Targeted Cancer Therapies

Penetrium Bioscience reveals new clinical strategy to combat drug resistance in cancer therapies at AACR 2026, launching Phase 2 trials.

ABL209: The Promising Dual Antibody ADC Revolutionizing Cancer Treatment in 2026

ABL Bio's ABL209 shows promising anti-cancer effects with broad safety in preclinical studies, advancing to Phase 1 trials in the U.S.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.